Bellerophon Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Location
184 Liberty Corner Road, Suite 302, Warren, NJ

There are no Buy or Sell transactions made by insiders since 10/14/2024

Bellerophon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Fernandes Chief Executive Officer, Principal Financial and Accounting Officer $154K Jun 7, 2023
Puissance Life Science Opportunities Fund VI 10%+ Owner $112K Jun 7, 2023
Parag Shah VP of Business Operations $77.8K Jun 7, 2023
Martin Dekker VP of Engineering & Manufacturing $77.8K Jun 7, 2023
Nicholas Laccona Financial Officer, (Pfo & Pao) $77.3K Feb 10, 2023
Bobae Kim VP Reg. Affairs & Quality $76.2K Jun 7, 2023
Naseem Amin Director $30.3K Jun 7, 2023
Crispin Teufel Director $22.2K Jun 7, 2023
Scott P. Bruder Director $22.2K Jun 7, 2023
Mary Ann Cloyd Director $22.2K Jun 7, 2023
Theodore T. Wang Director $22.2K Jun 7, 2023
Puissance Capital Management LP 10%+ Owner Oct 13, 2023

Recent Insider Transactions by Companies or Individuals for Bellerophon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.